Bioptimus partners with Cancer Research Horizons to advance AI-powered precision medicine
Bioptimus aims to use Cancer Research Horizons’ data to train and evaluate its AI foundation model
Credit: Gorodenkoff/Shutterstock
The agreement gives Bioptimus access to one of the UK's most comprehensive colorectal cancer datasets, adding its first UK patient cohort to the company's global multimodal tissue atlas
Register for FREE to keep reading
Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with:
- Insights into HPC, AI, lab informatics & data
- Curated content for life sciences, engineering & academia
- Access to Breakthroughs: real-world computing success
- Free reports & panels, including the Lab Informatics Guide
- White Papers & software updates for smarter research
Sign up now
Already a member? Log in here
Your data is protected under our privacy policy.
